T Marth
Overview
Explore the profile of T Marth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
633
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biagi F, Schiepatti A, Badulli C, Sbarsi I, Trotta L, Feurle G, et al.
Eur J Clin Microbiol Infect Dis
. 2015 Jul;
34(9):1919-21.
PMID: 26154181
Whipple's disease (WD) is a rare systemic condition caused, in genetically predisposed subjects, by Tropheryma whipplei, a common bacterium widespread in the environment. The relevance of genetic predisposition in WD...
2.
Hagel S, Epple H, Feurle G, Kern W, Lynen Jansen P, Malfertheiner P, et al.
Z Gastroenterol
. 2015 May;
53(5):418-59.
PMID: 25965989
No abstract available.
3.
Marth T
Aliment Pharmacol Ther
. 2015 Feb;
41(8):709-24.
PMID: 25693648
Background: The classical form of Whipple's disease (WD), clinically characterised by arthropathy, diarrhoea and weight loss, is rare. Recently, other more frequent forms of Tropheryma whipplei infection have been recognised....
4.
Kalsch J, Bechmann L, Manka P, Kahraman A, Schlattjan M, Marth T, et al.
Z Gastroenterol
. 2013 Jan;
51(1):26-31.
PMID: 23315648
Background And Aims: Liver and gut not only share alimentary but also immunological features. Major histocompatibility complex class I-related chains A and B (MIC A/B) function as indicators for cellular...
5.
Biagi F, Badulli C, Feurle G, Muller C, Moos V, Schneider T, et al.
Eur J Clin Microbiol Infect Dis
. 2012 Aug;
31(11):3145-50.
PMID: 22847580
Whipple's disease (WD) is a very rare chronic systemic condition characterised by a Th2/T regulatory (Treg) dysregulated immune response versus Tropheryma whipplei, a bacterium widely diffuse in the environment. To...
6.
Kraemer M, Kirschmeier A, Marth T
Int J Colorectal Dis
. 2008 Jun;
23(10):965-9.
PMID: 18553089
Purpose: Infliximab may represent an adjuvant to surgical therapy in patients with severe anal Crohn's disease as it has been shown to affect rapid remissions in a proportion of cases....
7.
Schmidt C, Giese T, Goebel R, Schilling M, Marth T, Ruether A, et al.
Int J Colorectal Dis
. 2007 Feb;
22(9):1013-20.
PMID: 17318554
Background And Aims: It has been suggested that Crohn's Disease (CD) is associated with an elevated T helper 1 response as manifested by increased production of interleukin-18 (IL-18). Local concentrations...
8.
Marth T
Praxis (Bern 1994)
. 2007 Jan;
96(1-2):13-7.
PMID: 17256556
Whipple's disease is a rare infectious disorder affecting mostly middle aged men. The causative organism, Tropheryma whipplei, recently has been cultivated and phylogenetically identified as an actinomycete. The rareness of...
9.
Deriban G, Marth T
Curr Med Chem
. 2006 Nov;
13(24):2921-6.
PMID: 17073638
Whipple's disease (WD) is a rare chronic infectious disorder caused by the rod- shaped bacterium Tropheryma whipplei. The disorder is characterized clinically by arthralgia, abdominal pain, diarrhea, malabsorbtion and progressive...
10.
Kalt A, Schneider T, Ring S, Hoffmann J, Zeitz M, Stallmach A, et al.
Int J Colorectal Dis
. 2005 May;
21(2):114-20.
PMID: 15875203
Background: An impaired production of interleukin (IL)-12 and T cell interferon-gamma (IFN-gamma) of in vitro stimulated monocytes has been discussed as a pathogenic factor in Whipple's disease (WD). It is...